Cuproptosis-Related Gene-SLC31A1, FDX1 and ATP7B-Polymorphisms are Associated with Risk of Lung Cancer

被引:36
|
作者
Yun, Yuhui [1 ]
Wang, Yun [2 ]
Yang, Ende [1 ]
Jing, Xin [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710038, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Med Oncol, Xian 710038, Shaanxi, Peoples R China
关键词
lung cancer; single-nucleotide polymorphisms; SNPs; solute carrier family 31 member 1; ferredoxin; 1; FDX1; ATPase copper transporting beta; ATP7B; PLATINUM-BASED CHEMOTHERAPY; GENETIC POLYMORPHISMS; COPPER TRANSPORTERS; ATP7B; FERREDOXINS; PREDICTION; CISPLATIN; TOXICITY; SLC31A1; ROLES;
D O I
10.2147/PGPM.S372824
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Cuproptosis is a novel copper-dependent cell death, and the copper level was increased in lung cancer patients. However, few studies evaluated the association between single-nucleotide polymorphisms (SNPs) in cuproptosis-related genes and lung cancer risk.Methods: Six SNPs of the SLC31A1, FDX1 and ATP7B genes were genotyped in a case-control cohort including 650 lung cancer cases and 650 controls using the MassARRAY platform.Results: The minor alleles of SLC31A1-rs10981694 and FDX1-rs10488764 were associated with an increased risk of lung cancer (rs10981694: OR=1.455, 95% CI: 1.201-1.763, p<0.001; rs10488764: OR=1.483, 95% CI: 1.244-1.768, p<0.001). In contrast, the minor alleles of rs9535826 and rs9535828 in ATP7B were related to a decreased risk of the disease (rs9535826: OR=0.714, 95% CI: 0.608-0.838 p<0.001; rs9535828: OR=0.679, 95% CI: 0.579-0.796, p<0.001). The frequencies of rs10981694-TG/GG and rs10488764-GA/AA genotypes were significantly higher in lung cancer cases than that in controls, making them risk genotypes for the disease (p < 0.001); while the rs9535826-TG/GG and rs9535828-GA/AA genotypes were protective genotypes and associated with a reduced risk of the disease (p<0.001). Genetic model evaluation revealed that SLC31A1-rs10981694 and FDX1-rs10488764 were associated with a growing risk of lung cancer in dominant, recessive and log-additive models (p<0.001). Moreover, rs9535826 and rs9535828 in ATP7B were related to a declining risk of the disease in three genetic models (p<0.001). In addition, stratification analysis showed that FDX1-rs10488764 was risk variant for lung cancer in both smokers and nonsmokers, and was associated with risk of each pathological type of lung cancer (p<0.008).Conclusion: The results shed new light on the correlation between cuproptosis-related genes and risk of lung cancer.
引用
收藏
页码:733 / 742
页数:10
相关论文
共 50 条
  • [31] Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression
    Deng, Ruiyun
    Zhu, Lili
    Jiang, Jun
    Chen, Jing
    Li, Hua
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (03): : 647 - 658
  • [32] Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy
    Fujita, Kazuma
    Motoyama, Satoru
    Sato, Yusuke
    Wakita, Akiyuki
    Nagaki, Yushi
    Minamiya, Yoshihiro
    Miura, Masatomo
    MEDICAL ONCOLOGY, 2021, 38 (01)
  • [33] Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy
    Kazuma Fujita
    Satoru Motoyama
    Yusuke Sato
    Akiyuki Wakita
    Yushi Nagaki
    Yoshihiro Minamiya
    Masatomo Miura
    Medical Oncology, 2021, 38
  • [34] Esculetin modulates SLC31A1 and ATP7B to influence copper homeostasis and trigger cell death in colorectal cancer
    Guo, Fangyue
    Liu, Mengying
    Zhu, Kaihe
    Ru, Jiapeng
    Li, Pei
    Zhang, Shanfeng
    CANCER RESEARCH, 2024, 84 (06)
  • [35] [Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer
    Luo, Linfeng
    Li, Anlin
    Fu, Sha
    Du, Wei
    He, Li-Na
    Zhang, Xuanye
    Wang, Yixing
    Zhou, Yixin
    Yunpeng, Yang
    Li, Zhang
    Hong, Shaodong
    IMMUNOLOGIC RESEARCH, 2023, 71 (02) : 213 - 228
  • [36] [Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer
    Linfeng Luo
    Anlin Li
    Sha Fu
    Wei Du
    Li-Na He
    Xuanye Zhang
    Yixing Wang
    Yixin Zhou
    Yang Yunpeng
    Zhang Li
    Shaodong Hong
    Immunologic Research, 2023, 71 : 213 - 228
  • [37] Polymorphisms of the interleukin-1β gene are associated with increased risk of non-small cell lung cancer
    Zienolddiny, S
    Ryberg, D
    Maggini, V
    Skaug, V
    Canzian, F
    Haugen, A
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 353 - 356
  • [38] CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
    Zhan, Ping
    Wang, Qin
    Qian, Qian
    Wei, Shu-Zhen
    Yu, Li-Ke
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [39] CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
    Ping Zhan
    Qin Wang
    Qian Qian
    Shu-Zhen Wei
    Li-Ke Yu
    Journal of Experimental & Clinical Cancer Research, 30
  • [40] Potentially Functional Polymorphisms in POU5F1 Gene Are Associated with the Risk of Lung Cancer in Han Chinese
    Niu, Rui
    Wang, Yuzhuo
    Zhu, Meng
    Wen, Yifan
    Sun, Jie
    Shen, Wei
    Cheng, Yang
    Zhang, Jiahui
    Jin, Guangfu
    Ma, Hongxia
    Hu, Zhibin
    Shen, Hongbing
    Dai, Juncheng
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015